328 related articles for article (PubMed ID: 12476348)
1. Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease.
Mattson MP
J Neurovirol; 2002 Dec; 8(6):539-50. PubMed ID: 12476348
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
3. Neuronal and glial calcium signaling in Alzheimer's disease.
Mattson MP; Chan SL
Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
[TBL] [Abstract][Full Text] [Related]
4. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
5. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
Lee J; Chan SL; Mattson MP
Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
[TBL] [Abstract][Full Text] [Related]
6. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
7. Numb modifies neuronal vulnerability to amyloid beta-peptide in an isoform-specific manner by a mechanism involving altered calcium homeostasis: implications for neuronal death in Alzheimer's disease.
Chan SL; Pedersen WA; Zhu H; Mattson MP
Neuromolecular Med; 2002; 1(1):55-67. PubMed ID: 12025816
[TBL] [Abstract][Full Text] [Related]
8. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
Chan SL; Furukawa K; Mattson MP
Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
[TBL] [Abstract][Full Text] [Related]
9. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
10. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease.
Mattson MP; Pedersen WA
Int J Dev Neurosci; 1998; 16(7-8):737-53. PubMed ID: 10198821
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer's disease: new prospects in therapy and applied experimental models].
Kubis AM; Janusz M
Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of calcium in Alzheimer's disease.
Brzyska M; Elbaum D
Acta Neurobiol Exp (Wars); 2003; 63(3):171-83. PubMed ID: 14518509
[TBL] [Abstract][Full Text] [Related]
13. Neuronal calcium signaling and Alzheimer's disease.
Woods NK; Padmanabhan J
Adv Exp Med Biol; 2012; 740():1193-217. PubMed ID: 22453989
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.
Magi S; Castaldo P; Macrì ML; Maiolino M; Matteucci A; Bastioli G; Gratteri S; Amoroso S; Lariccia V
Biomed Res Int; 2016; 2016():6701324. PubMed ID: 27340665
[TBL] [Abstract][Full Text] [Related]
15. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease.
Kanamaru T; Kamimura N; Yokota T; Iuchi K; Nishimaki K; Takami S; Akashiba H; Shitaka Y; Katsura K; Kimura K; Ohta S
Neurosci Lett; 2015 Feb; 587():126-31. PubMed ID: 25529196
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
18. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
20. Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.
Camandola S; Mattson MP
Biochim Biophys Acta; 2011 May; 1813(5):965-73. PubMed ID: 20950656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
